DUBLIN, Aug. 25, 2022 /PRNewswire/ -- The "Global Alzheimer'S Disease Therapeutics and Diagnostics Market 2022-2028" report has been added to ResearchAndMarkets.com's offering.
The publisher estimates the global AlzheimerAlzheimer's disease therapeutics and diagnostics market to grow with a CAGR of 6.98% in the years 2022-2028. The high prevalence of Alzheimer's disease (AD) and the growing elderly populace are key factors driving the growth of this market. The elderly population is at an increased risk of developing this disease, which is expected to aid the demand for therapeutics and diagnostics. However, stringent regulations by the government, as well as the failure of the late-stage drugs in clinical trials, are hampering the growth of this industry. On the bright side, the emergence of novel diagnostic technologies for AD treatment is creating new avenues for the market's development. The global market for Alzheimer's therapeutics and diagnostics spans Europe, the Asia-Pacific, Latin America, the Middle East and Africa, and North America.
North America held the largest share in the global market in 2021, and is anticipated to maintain its lead by the end of the forecast period. Developed nations, such as the US and Canada, are considered in the market in this region. Factors such as the rising geriatric population and the growing burden of Alzheimer's disease contribute to the growth of the market in North America. Statistics indicate that 1 in every 9 people in the US, aged 65 years or older, is affected by AD. This has enhanced the demand for developing novel therapeutics and diagnostics for Alzheimer's. Rise in the Elderly Population
Failure of Late-Stage Drugs
Stringent Government Regulations
Growing Number of Pipeline Drugs
3.2.1. Late Stage: Severe Ad 3.2.2. Early/Middle Stage: Mild to Moderate Ad 4.3. Electroencephalography
4.4. Magnetic Resonance Imaging
For more information about this report visit https://www.researchandmarkets.com/r/fe9ywz
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg